These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6278552)

  • 1. Properties of hepatic and pancreatic cyclic AMP phosphodiesterase in the cat.
    Sakane Y; Morgan PR; Glenn TM
    Res Commun Chem Pathol Pharmacol; 1981 Nov; 34(2):251-66. PubMed ID: 6278552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Croton oil- and benzo(a)pyrene-induced changes in cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate phosphodiesterase activities in mouse epidermis.
    Verma AK; Froscio M; Murray AW
    Cancer Res; 1976 Jan; 36(1):81-7. PubMed ID: 174815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of 3',5'-cyclic-AMP phosphodiesterase from Paragonimus africanus metacercariae.
    Walter RD
    Tropenmed Parasitol; 1976 Sep; 27(3):337-42. PubMed ID: 10655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new method for measurement of cyclic AMP phosphodiesterase activity.
    Han GY; Han PF; Owen GS; Johnson J
    J Biochem; 1977 Aug; 82(2):387-94. PubMed ID: 199581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of high-affinity cyclic adenosine 5'-monophosphate phosphodiesterases from human acute myelogenous leukemic cells.
    Onali P; Strada SJ; Chang L; Epstein PM; Hersh EM; Thompson WJ
    Cancer Res; 1985 Mar; 45(3):1384-91. PubMed ID: 2982489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interaction between cyclic adenosine-3':5'-monophosphate phosphodiesterase and structural analogs of the substrate].
    Kochetkova MN; Guliaev NN; Tunitskaia VL; Severin ES
    Biokhimiia; 1981 Feb; 46(2):353-60. PubMed ID: 6264977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a spectrophotometric assay for cAMP phosphodiesterase.
    Dedman JR; Means AR
    J Cyclic Nucleotide Res; 1977 Apr; 3(2):139-52. PubMed ID: 195985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation by fast-atom bombardment/mass-analysed ion kinetic energy spectrometry: kinetic analysis of cyclic nucleotide phosphodiesterase activity.
    Newton RP; Walton TJ; Brenton AG; Kingston EE; Harris FM
    Rapid Commun Mass Spectrom; 1989 Jun; 3(6):178-82. PubMed ID: 2562450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taste bud adenosine -3'5'-monophosphate phosphodiesterase: activity, subcellular distribution and kinetic parameters.
    Law JS; Henkin RI
    Res Commun Chem Pathol Pharmacol; 1982 Dec; 38(3):439-52. PubMed ID: 6298918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of renal ecto-phosphodiesterase.
    Jackson EK; Ren J; Zacharia LC; Mi Z
    J Pharmacol Exp Ther; 2007 May; 321(2):810-5. PubMed ID: 17308037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple forms of cyclic nucleotide phosphodiesterase in a murine adrenal cortex cell line (Y-1).
    Ryan JA; Toscano WA
    Arch Biochem Biophys; 1985 Sep; 241(2):403-12. PubMed ID: 2994565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
    Zhou L; Thompson WJ; Potter DE
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1745-52. PubMed ID: 10393044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic nucleotide phosphodiesterase in the aorta of spontaneously hypertensive rats : variation with age and effect of propranolol.
    Bucher B; Stoclet JC
    Artery; 1980; 7(1):44-55. PubMed ID: 6264899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new method for separating cyclic AMP from 5'-AMP with application to the assay for cyclic AMP phosphodiesterase.
    Sinha AK; Colman RW
    Anal Biochem; 1981 May; 113(2):239-45. PubMed ID: 6269457
    [No Abstract]   [Full Text] [Related]  

  • 16. A semiautomated method for the assay of cyclic adenosine 5'-monophosphate phosphodiesterase.
    Daniels DV; Alvarez R
    Anal Biochem; 1996 May; 236(2):367-9. PubMed ID: 8660523
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of cyclic AMP phosphodiesterase in microdissected periportal and perivenous rat liver tissue with different dietary states.
    Runge D; Jungermann K
    Histochemistry; 1991; 96(1):87-92. PubMed ID: 1718930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic AMP phosphodiesterase activity in rat brain following chronic treatment with lithium, imipramine, reserpine, and combinations of lithium with imipramine or reserpine.
    Andersen PH; Klysner R; Geisler A
    Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):337-43. PubMed ID: 6316725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of micromethods to resolve problems of human breast tumor heterogeneity in analysis of cyclic 3':5'-nucleotide phosphodiesterase.
    Larner EH; Rutherford CL
    Cancer Res; 1982 May; 42(5):1661-8. PubMed ID: 6279280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
    Ilien B; Ruckstuhl M; Landry Y
    J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.